Caxton Corp Portfolio Holdings

Caxton Corp has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $16.2 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Xeris Biopharma Holdings, Inc. with a value of $11.3M, Rezolute, Inc. with a value of $3.36M, Spdr S&P 500 ETF Trust with a value of $970K, Berkshire Hathaway Inc Class B with a value of $428K, and Compass Therapeutics, Inc. with a value of $86K.

Examining the 13F form we can see an decrease of $1.17M in the current position value, from $17.4M to 16.2M.

Caxton Corp is based out at Princeton, NJ

Below you can find more details about Caxton Corp portfolio as well as his latest detailed transactions.